NCT02770131已完成不适用
Observational Serial Chart Review of Repatha® Use in European Subjects With Hyperlipidaemia
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- Amgen
- 入组人数
- 1,986
- 试验地点
- 1
- 主要终点
- Description of clinical characteristics of subjects initiated on Repatha®
研究概览
简要总结
Review of clinical characteristics of patients who are prescribed Repatha® and how their treatment is managed.
研究设计
- 研究类型
- Observational
- 观察模型
- Other
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 100 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Adults (>18 years) Provided informed consent Initiated on Repatha® at physician's discretion, after 1st August 2015 Received at least one dose of Repatha®
排除标准
- •Enrolled in an interventional study of PCSK9 inhibitor within 12 weeks prior to initiation of Repatha® Received commercially available PCSK9 inhibitor within 12 weeks prior to initiation of Repatha®
结局指标
主要结局
Description of clinical characteristics of subjects initiated on Repatha®
时间窗: Study day 1
Age at initiation of Repatha®, Gender Familial hypercholesterolaemia status Diabetic status, Cardiovascular history History of statin intolerance
次要结局
- Describe Repatha® dose over time(From the first dose of Repatha® up to 30 months post first dose)
- Describe hospitalizations(From the first dose of Repatha® up to 30 months post first dose)
- Describe Repatha® administrative device use over time(From the first dose of Repatha® up to 30 months post first dose)
- Describe LDL-C and other cholesterol values over time(Up to 26 weeks prior to the first dose of Repatha®, up to 30 months post first dose of Repatha®)
- Describe use of other lipid-modifying therapies(From the first dose of Repatha® up to 30 months post first dose)
- Describe Physician visits(From the first dose of Repatha® up to 30 months post first dose)
- Describe Repatha® dose frequency over time(From the first dose of Repatha® up to 30 months post first dose)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Observational Follow-up Study of REGATTAUrinary Tract InfectionsNCT03176563University Medical Center Goettingen398
已完成
不适用
A Study Of Indian Patients Receiving Therapy For Systemic Fungal InfectionsSystemic Fungal InfectionsNCT00721578Pfizer23
已完成
不适用
InO - A Retrospective Study of UK Patients With LeukaemiaPrecursor Cell Lymphoblastic Leukemia-LymphomaNCT04456959Pfizer28
已完成
不适用
A Study on Rheumatoid Arthritis Patients Treated With RituximabRheumatoid ArthritisNCT02622503Hoffmann-La Roche81
终止
不适用
A Chart Review of Rituximab Plus Repeated Cycles of DexamethasoneIdiopathic Thrombocytopenia PurpuraNCT02050581Weill Medical College of Cornell University72